chartexchange

SGMO
SANGAMO THERAPEUTICS INC
stockOTC

InactiveJun 23, 2026
0.074USD-57.532%(-0.10)54,776,712
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
CEO
Alexander Macrae
HQ
Brisbane, California, USA
SGMO Profile

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.

SGMO Performance
PeriodPriceDateChange